Leads Biolabs LBL-034 Multiple-Myeloma ASH Data Shows 82% ORR
Nanjing Leads Biolabs Co., Ltd. (HKG: 9887) reported Phase 1/2 data for LBL-034 in relapsed/refractory multiple...
Junshi Biosciences roconkibart psoriasis NMPA Acceptance
Shanghai Junshi Biosciences Co., Ltd. (HKG: 1877, SHA: 688180) announces that the National Medical Products...
CSPC SYH2069 GLP-1/GIP Dual Agonist Wins FDA Nod for Obesity
CSPC Pharmaceutical Group Limited (HKG: 1093) announced that SYH2069 Injection, its GLP-1/GIP receptor dual-biased agonist...
Asieris APL-1401 Ulcerative-Colitis Phase 1b Data Positive
Asieris Pharmaceuticals (SHA: 688176) presented Phase 1b trial data for APL-1401 in moderate-to-severe active ulcerative...
Balance Medical ePTFE Pericardial-Membrane Gets NMPA Nod, Ends Import Reliance
Beijing Balance Medical Technology Co., Ltd. (SHA: 688198) announced that its expanded polytetrafluoroethylene (ePTFE) pericardial...
Shanghai Pharma X842 Deal Termination with Sinorda
Shanghai Pharmaceuticals Holding Co., Ltd. (SPH, HKG: 2607, SHA: 601607) announced the termination of its...
Weixikang Lidocaine-Tetracaine Cream NMPA Clinical Trial Approval
Tibet Weixikang Pharmaceutical Co., Ltd. (SHA: 603676) announced that its lidocaine-tetracaine cream has received approval...
Anke-Biotech PA3-17 CAR-T Pediatric Indication NMPA Accepted
Anhui Anke Biotechnology (Group) Co., Ltd. (SHE: 300009) announced that the China National Medical Products...
Mirxes XtalPi AI Platform Targets Asian GI Cancers
Mirxes Holding Company Limited (HKG: 2629) announced it has entered into a memorandum of understanding...
Sirnaomics ChemPartner GalAhead Nucleic-Acid Deal
Sirnaomics Ltd. (HKG: 2257) announced a global non‑exclusive licensing agreement with ChemPartner Co., Ltd. (SHE:...
NHSA 2025 Drug Lists Add 114 Medical Insurance Drugs, 19 Commercial
The National Healthcare Security Administration (NHSA) released the 2025 National Medical Insurance Drug List and...
OTR Therapeutics Series-A Raises $100M for Neurology Pipeline
OTR Therapeutics Limited announced the successful completion of a USD 100 million Series A financing,...
Sanofi Completes Vicebio $1.6B Acquisition, Adds RSV Vaccine Platform
Sanofi (NASDAQ: SNY) announced the completion of its $1.6 billion acquisition of Vicebio, first announced in...
Juventas CAR-T LBCL Launch Marks Second Indication
Juventas Cell Therapy Ltd announced the commercial launch of inaticabtagene autoleucel for relapsed or refractory...
BMS Breyanzi MZL FDA Approval First CAR-T
Bristol-Myers Squibb (BMS, NYSE: BMY) announced that the FDA has approved Breyanzi (lisocabtagene maraleucel; liso-cel)...
Formosa Pharma APP13007 Clobetasol ASEAN Deal with Rxilient
Formosa Pharmaceuticals, Inc. (TPE: 6838) announced an exclusive licensing agreement with Rxilient Medical Pte. Ltd.,...
Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint
Novo Nordisk (NYSE: NVO) reported at the Clinical Trials on Alzheimer’s Disease conference that semaglutide...
Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures
Acotec Scientific Holdings Limited (HKG: 6669) announced it has received registration approval from China’s National...
Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes
Youjia Biomedical Technology and Hangzhou Tongee Medical Technology Co., Ltd officially signed a strategic cooperation...
Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod
Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196, HKG: 2196) announced that its FXS0887 tablet has...